SCHEMBL6924459

SCHEMBL6924459

O=C1c2cc3ccccc3cc2C(=O)N1c1ccccc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 2/20 0.61
▸ HSPA1A P0DMV8 1/20 0.52
▸ PABPC1 P11940 1/20 0.52
▸ NR1H3 Q13133 1/20 0.49
▸ CA12 O43570 2/20 0.48
▸ CA9 Q16790 2/20 0.48
▸ CA1 P00915 1/20 0.48
▸ CA2 P00918 1/20 0.48
▸ SCN2A Q99250 1/20 0.48
▸ KMT2A Q03164 3/20 0.48
▸ MEN1 O00255 2/20 0.48
▸ RXFP1 Q9HBX9 2/20 0.48
▸ GRM5 P41594 1/20 0.47
▸ GAA P10253 2/20 0.47
▸ PKM P14618 1/20 0.47
▸ TLR9 Q9NR96 1/20 0.47
▸ ALDH1A1 P00352 4/20 0.47
▸ NPSR1 Q6W5P4 2/20 0.47
▸ CES2 O00748 1/20 0.47
▸ BCHE P06276 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30999724 0.83 ALDH1A1 (0.47) ESR1CA12CA9CA1CA2
N-Phenyl-Phthalimide SCHEMBL123618 0.81 KMT2A (0.68) ESR1HSPA1APABPC1NR1H3CA12
N-Phenyl-Phthalimide SCHEMBL29819622 0.81 KMT2A (0.68) ESR1HSPA1APABPC1NR1H3CA12
SCHEMBL19773976 0.81 KMT2A (0.68) ESR1HSPA1APABPC1NR1H3CA12
SCHEMBL28086894 0.81 ESR1 (0.59) ESR1HSPA1APABPC1NR1H3CA12
SCHEMBL29710393 0.81 ESR1 (0.59) ESR1HSPA1APABPC1NR1H3CA12
SCHEMBL29710383 0.81 CA9 (0.66) ESR1HSPA1APABPC1NR1H3CA12
SCHEMBL9633890 0.81 CA9 (0.66) ESR1HSPA1APABPC1NR1H3CA12
SCHEMBL25776876 0.80 BRD4 (0.59) ESR1KMT2AMEN1GAAPKM
N-Phenyl-Phthalimide SCHEMBL27271803 0.79 KMT2A (0.65) ESR1HSPA1APABPC1NR1H3CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6515129-B1 A pharmaceutical composition which comprises, a cyclic imide derivative represented by the general formula (I): present invention relates to an aminopeptidase N inhibitor or an angiogenesis inhibitor, modulates production of tumor necrosis ISHIHARA SANGYO KAISHA LTD. (JP) 2003-02-04 — — US disclosed
US-6429212-B1 AMINOPEPTIDASE N INHIBITOR USED TO TREAT CANCER, TUMORS, AND RETINOPATHY; FEW SIDE EFFECTS; ANGIOGENESIS INHIBITOR ISHIHARA SANGYO KAISHA LTD. (JP) 2002-08-06 — — US disclosed
Send feedback